PSYC 373 Psychopharmacology

Updated to reflect the new DSM-5 classification, this revised Fifth Edition maintains the user-friendly structure of its predecessors while offering in-depth coverage of the latest research in pharmacological principles, classes of drugs, and psychiatric disorders. Introductory chapters provide a theoretical grounding in clinical applications. The bulk of the book is devoted to various classes of drugs. Finally, the section on psychopharmacological treatment addresses evidence-based principles of clinical care for the full spectrum of mental disorders and conditions as well as for specific populations and circumstances

DSM-5-TR includes the fully revised text and references, updated diagnostic criteria and ICD-10-CM codes since DSM-5 was published in 2013. Stay current with these important updates in DSM-5-TR: Fully revised text for each disorder with updated sections on associated features, prevalence, development and course, risk and prognostic factors, culture, diagnostic markers, suicide, differential diagnosis, and more.

The manual offers thoroughly updated, exhaustively vetted, and evidence-based information on psychotropic drugs in a collegial, conversational style

Although clinical trials were virtually unheard of in psychiatryfor many years, they are now the gold standard for judging whether drugs are safe and useful. But should they be? What is the true status of clinical trials?

Treatment with drugs is fundamental to modern therapy of psychiatric disorders. The number of disorders responsive to drug treatment is increasing, reflecting the extensive synthesis of novel compounds and the greater understanding of the aetiology of the disorders.

Organized by disorder and, within each disorder, by medication, this book is designed to familiarize clinicians and students with the basic terminology and models of pharmacokinetics. This fully revised and updated eighth edition provides essential information on new medications and treatment options and includes the latest research on side effects, contraindications, and efficacy of all major medications prescribed for mental health disorders. The book also features an important new chapter on the effects of withdrawing from psychopharmacological medications.

Addresses the current "split" model of mental health care, in which physicians provide pharmaco-therapy while non-prescribing practitioners oversee other services such as psychotherapy. Bringing these two areas together, this book familiarizes mental health professionals with the medications used to treat psychiatric disorders.

Neuropsychopharmacology is a relatively new subject area in the neurosciences. It is a field of study that describes the effects of drugs from the molecular to the behavioural level and requires integration and synthesis of knowledge from various disciplines including neuroanatomy, physiology, molecular biology, pharmacology and the behavioural sciences. The principal aims of this book are to provide students with a clear understanding of CNS disorders, and an appreciation of how basic and clinical research findings can be translated into therapeutics.

The Wiley-Blackwell Handbook of Addiction Psychopharmacology is an authoritative collection of the most current research approaches to the study of drug addiction. Provides students and scholars with the practical tools to do the best work possible in addiction psychopharmacology Features reviews on the empirical relevance of the research methods and the nuances of the methodologies used Topics covered include core methods for assessing drug effects, distal and proximal determinants of drug use, and insights from cognitive neuroscience Includes contributions from a diverse range of experts that reflect the multidisciplinary nature of the field

We're all familiar with the idea that plant-derived chemicals can have an impact on the functioning of the human brain. This book sets out to describe not only how, in terms of pharmacology or psychopharmacology, but more importantly why plant- and fungus-derived chemicals have their effects on the human brain.

Outlines a comprehensive, evidence-based approach to coordinating psychopharmacological and psychotherapeutic treatments. There is a burgeoning movement in mental health to acknowledge the entire person's functioning across physical, psychological and social spheres, and to integrate medical as well as psychological and social interventions to address the entire spectrum of presenting problems. Each disorder-specific chapter is authored by a prescriber and psychotherapist team who consider all the evidence around treatments and combinations, providing outcome conclusions and concise tables of recommended front-line interventions.